CaPSURE: UCSF Cancer of the Prostate Strategic Urologic Research Endeavor
CaPSURE™ is a longitudinal, observational study of approximately 15,000 men with all stages of biopsy-proven prostate cancer. Patients have enrolled at 43 community urology practices, academic medical centers, and VA hospitals throughout the United States since 1995.
Physicians provide clinical data on their patients who have consented to be in the study:
• methods of screening
• PSA values at diagnosis and at every patient visit
• diagnostic and pathologic Gleason grade and stage
• surgical pathology
• primary, neoadjuvant, adjuvant, and salvage treatments
Patients contribute data before and at regular intervals after treatment:
• urinary, bowel, and sexual function
• general health
• comorbid conditions and medications
• lifestyle modification needed after diagnosis or treatment of prostate cancer
• satisfaction with medical care
CaPSURE™ research findings have expanded knowledge of prostate cancer risk prediction, diagnostic trends, treatment patterns, outcomes and quality of life. CaPSURE™ investigators have published more than 177 articles in peer-reviewed journals and presented over 200 papers at professional conferences. Fellows, residents, and medical students, both at UCSF and at outside institutions, have authored many of the publications under the direction of senior investigators. The experience gained by these junior investigators has helped to shape and accomplish career goals.
If your urology practice is interested in becoming a core research CaPSURE™ site, please contact Jeanette Broering, PhD, MPH, RN Director of Data Procurement and Quality Assurance.
The CaPSURE™ study is funded and coordinated by the UCSF Department of Urology.
Our extensive lists of publications can be seen by clicking here.
UCSF investigators may apply to use research data from the UCSF Department of Urology.